Healthequity, Inc. cash flow statement HQY

In Q2 of fiscal 2027, the quarter ended Jul 31, 2026, Healthequity, Inc. generated $136.2 million of cash from operations, up 0.2% from the same quarter a year earlier. It spent $978,000 on capital expenditures. That left free cash flow of $135.2 million. The company returned $107.7 million in share buybacks to shareholders.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Jul 31, 2026
Q2 FY2027
Jul 31, 2026
Q1 FY2027
Apr 30, 2026
Q4 FY2026
Jan 31, 2026
Q3 FY2026
Oct 31, 2025
Q2 FY2026
Jul 31, 2025
Q1 FY2026
Apr 30, 2025
Q4 FY2025
Jan 31, 2025
Q3 FY2025
Oct 31, 2024
Operating
Depreciation and amortization
158
+0.3%
42
+9.1%
38
-1.4%
39
-1.3%
39
-4.8%
38
-11.8%
39
-0.5%
39
+3.4%
41
+7.8%
Stock-based compensation
81
+6.6%
22
+16.5%
19
+35.4%
19
-11.9%
21
-2.8%
19
-11.6%
14
-55.2%
22
+26.1%
21
-2.5%
Operating cash flow
490
+33.6%
136
+0.2%
98
+50.6%
118
+55.7%
139
+53.0%
136
+25.7%
65
-1.1%
76
-1.7%
91
+58.6%
Investing
Capital expenditures
2
+65.4%
1
+26.5%
0
+320.9%
0
-0.6%
1
+166.7%
1
+4.3%
0
-88.1%
0
-41.4%
0
-46.0%
Investing cash flow
-60
-11.0%
-26
-131.8%
-14
+13.9%
-8
+37.8%
-11
+11.5%
-11
+94.7%
-16
+94.0%
-14
-20.3%
-13
+16.6%
Financing
Debt issued
—
—
—
0
0
-100.0%
0
-100.0%
0
-100.0%
0
512
Debt repaid
77
-87.4%
12
-76.2%
15
25
+0.0%
25
-95.3%
50
—
25
537
Stock buybacks
404
108
+61.4%
123
+108.8%
81
+28.6%
92
+58.0%
67
59
63
59
Financing cash flow
-479
-42.7%
-120
-10.6%
-137
-142.2%
-100
-12.9%
-122
-48.5%
-108
-161.2%
-57
-209.4%
-88
-2248.4%
-82
-4163.9%
Change in cash
Net change in cash
-48
-116.0%
-9
-156.5%
-54
-565.0%
10
+136.9%
5
+201.4%
17
-78.1%
-8
+94.7%
-26
-137.5%
-5
-110.8%
Free cash flow
488
+33.5%
135
+0.1%
97
+50.3%
118
+55.9%
138
+52.7%
135
+25.8%
65
-0.1%
75
-1.4%
90
+59.6%
Per share
Free cash flow per share
5.69
+38.0%
1.61
+4.5%
1.14
+56.3%
1.36
+60.8%
1.58
+55.6%
1.54
+27.1%
0.73
-0.2%
0.85
-3.1%
1.02
+56.8%
Shareholder returns
Returned to shareholders
404
108
123
81
92
67
59
63
59
Share of free cash flow
82.94%
79.70%
126.91%
68.90%
67.08%
49.41%
91.36%
83.51%
64.83%
Ratios
Free cash flow margin
35.81%
38.54%
27.40%
35.14%
42.77%
41.46%
19.54%
24.19%
30.04%
Capital expenditures to revenue
0.18%
0.28%
0.10%
0.10%
0.24%
0.24%
0.03%
0.11%
0.10%
Stock-based compensation to revenue
5.97%
6.33%
5.47%
5.71%
6.38%
5.85%
4.33%
6.96%
7.03%
Cash conversion
2.07x
2.07x
1.40x
2.37x
2.68x
2.27x
1.20x
2.87x
15.88x
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Business Services, NEC (SIC 7389)
Listed as
HQY (Nasdaq)
Fiscal year ends
January 31
Incorporated in
DE
Headquarters
Draper, UT
SEC filer status
Large accelerated filer
SEC CIK
1428336
Former names
HEALTHEQUITY INC (until Jun 6, 2019)

Other Services-Business Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.